Bachem Revenue and Competitors

Barramornie, AU

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bachem's estimated annual revenue is currently $342.7M per year.(i)
  • Bachem's estimated revenue per employee is $201,000

Employee Data

  • Bachem has 1705 Employees.(i)
  • Bachem grew their employee count by 5% last year.

Bachem's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Global Sales EnablementReveal Email/Phone
3
VP Peptide Manufacturing UpstreamReveal Email/Phone
4
Head ControllingReveal Email/Phone
5
Head CAPEX OligonucleotidesReveal Email/Phone
6
VP Global EngineeringReveal Email/Phone
7
VP Materials ManagementReveal Email/Phone
8
VP Head Global Project ManagementReveal Email/Phone
9
ControllerReveal Email/Phone
10
VP Global Supply Chain ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$62.9M3138%N/AN/A
#2
$26.5M1327%N/AN/A
#3
$20.5M1020%N/AN/A
#4
$18.3M916%N/AN/A
#5
$18.7M932%N/AN/A
#6
$72.2M3596%N/AN/A
#7
$55.3M2756%N/AN/A
#8
$35.8M1786%N/AN/A
#9
$31M1544%N/AN/A
#10
$70.8M3525%N/AN/A
Add Company

What Is Bachem?

Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership. Bachem. Pioneering Partner for Peptides Peptides, Biochemicals, Custom Synthesis, GMP, Active Pharmaceutical Ingredients (APIs), Regulatory Support, Dedicated Project Management

keywords:N/A

N/A

Total Funding

1705

Number of Employees

$342.7M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bachem News

2022-04-20 - Gonadorelin Market Size, Scope And Forecast | Ferring, Xuchang ...

Ferring, Xuchang Shangke Chemical, Bachem, Aspen Oss, Shenzhen JYMed Technology, Toronto Research Chemicals, LKT Laboratories, Hemmo...

2022-04-17 - Bachem's New Facilities For Large-Scale Oligonucleotide ...

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50...

2022-04-13 - Will Weakness in Bachem Holding AG's (VTX:BANB) Stock Prove Temporary Given Strong Fundamentals?

Bachem Holding (VTX:BANB) has had a rough three months with its share price down 13%. However, a closer look at its sound financials might...